CN1507893A - Composition for anti osteo porosis - Google Patents

Composition for anti osteo porosis Download PDF

Info

Publication number
CN1507893A
CN1507893A CNA021455791A CN02145579A CN1507893A CN 1507893 A CN1507893 A CN 1507893A CN A021455791 A CNA021455791 A CN A021455791A CN 02145579 A CN02145579 A CN 02145579A CN 1507893 A CN1507893 A CN 1507893A
Authority
CN
China
Prior art keywords
composition
crystal
bovis grunniens
yak
flos carthami
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA021455791A
Other languages
Chinese (zh)
Other versions
CN100387244C (en
Inventor
李天才
索有瑞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest Institute of Plateau Biology of CAS
Original Assignee
Northwest Institute of Plateau Biology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest Institute of Plateau Biology of CAS filed Critical Northwest Institute of Plateau Biology of CAS
Priority to CNB021455791A priority Critical patent/CN100387244C/en
Publication of CN1507893A publication Critical patent/CN1507893A/en
Application granted granted Critical
Publication of CN100387244C publication Critical patent/CN100387244C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a Chinese medicine composition for curing and preventing osteoporosis. Said composition is made up by using yak bone crystal, yak liver extract, ass-hide glue and safflower extract powder. Said Chinese medicine has the functions of supplementing calcium, raising femoral bone density, preventing osteoporosis and raising immunity of human body, so that it can obtain obvious therapeutic effect.

Description

Anti-osteoporotic composition
Technical field
The present invention relates to a kind of compositions of osteoporosis disease, especially a kind of Halth-care composition based on the osteoporosis disease on traditional Tibetan medicine basis.
Background technology
Along with the prolongation of people's average life and the reduction of birth rate, aged tendency of population is on the rise.According to statistics, China is the maximum country of aging population in the world, has entered aging country ranks.Osteoporosis whole body bone amount significantly reduces the situation of fracturing when consequently spontaneous fracture or slight damage taking place.Old people's sickness rate is very high, and at present China's patients with osteoporosis is about 8,400 ten thousand, accounts for 6% of total population.Therefore, the exploitation of osteoporosis disease nutritional health food and medicine is extremely urgent, and social meaning is great.
Studies show that: osteoporosis is not enough, excessive or uneven relevant with the diet picked-up of some mineral.Calcium is considered to the essential nutrients of bone health, and secondly bone metabolism also relates to mineral magnesium, sodium, phosphorus etc.Osteoporosis Therapeutic Method and clinical application on clinical medicine is varied.It is a lot of to advocate nourishing healthy and sport and body-building person.Os Bovis grunniens is traditional medication in Tibetan's medicine, has cold relieving, gain of heat amount, gives birth to stomach-fire, can the heal effectiveness of wound of bone marrow.Therefore, the someone develops the yak marrow tonic powder health food, this health food have replenish the calcium, function such as human body immunity improving power, and do not excavate the health care of its osteoporosis disease as yet.
Summary of the invention
The objective of the invention is for a kind of anti-osteoporotic composition is provided, said composition has the good functions such as femoral bmd, prevention of osteoporosis disease and enhancing human body immunity power of replenishing the calcium, increase, have balanced in nutrition to the middle-aged and senile osteoporosis patient, promoting blood circulation to remove obstruction in the collateral, the liver and the kidney tonifying, functions such as human body immunity improving power reach the purpose of prophylactic treatment middle-aged and senile osteoporosis.
Purpose of the present invention can realize by following measure:
A kind of anti-osteoporotic composition, said composition comprises following raw materials in percentage by weight:
Os Bovis grunniens crystal 10-80% yak liver extract 5-60%
Colla Corii Asini 5-50% Flos Carthami extract powder 5-50%.
The preparation method of described anti-osteoporotic composition comprises the steps: Os Bovis grunniens is obtained the Os Bovis grunniens crystal with the chemical method extraction separation; And extraction yak liver extract; Os Bovis grunniens crystal and yak liver extract, Colla Corii Asini, Flos Carthami extract powder can be made compositions by above-mentioned weight percentage mixing.
The present invention has following advantage compared to existing technology:
1, the present invention excavates and utilizes Os Bovis grunniens cold relieving, gain of heat amount in traditional Tibetan medicine and pharmacology, gives birth to stomach-fire, can the heal effectiveness of wound of its bone marrow, have abundant mineral composition in conjunction with Os Bovis grunniens, make compositions of the present invention have the efficacy effect of prophylactic treatment middle-aged and senile osteoporosis.
2, the present invention adopts the chemical method extraction separation with Os Bovis grunniens, and the Os Bovis grunniens crystal that is very easily dissolved, easily is absorbed by the body and utilize is aided with yak liver extract, Colla Corii Asini and Flos Carthami extract powder; This compatibility is taken into account the balanced in nutrition of patients with osteoporosis, has promoting blood circulation to remove obstruction in the collateral, the liver and the kidney tonifying, human body immunity improving power.
3, compositions of the present invention contains the nutrient substance composition that rich in protein, aminoacid, vitamin and mineral element etc. easily are absorbed by the body and utilize, and wherein protein, calcium and phosphorus are main functional component; Thereby the present invention has the good functions such as femoral bmd, prevention of osteoporosis disease and enhancing human body immunity power of replenishing the calcium, increase.
4, the present invention is applicable to that body calcium deficiency, femoral bmd reduce, the patients with osteoporosis of immunity degradation, is particularly useful for the middle-aged and senile osteoporosis patient and takes.
5, the present invention is bright through clinical 30 illustrations: said composition has the good functions such as femoral bmd, prevention of osteoporosis disease and enhancing human body immunity power of replenishing the calcium, increase.The said composition acute toxicity testing shows: the mice maximum tolerated dose belongs to nontoxic level material greater than the 21.5g/kg body weight.
Concrete embodiment
Embodiment one:
A kind of anti-osteoporotic composition is made health product by following raw materials in percentage by weight: Os Bovis grunniens crystal 75%, yak liver extract 15%, Colla Corii Asini 5%, Flos Carthami extract powder 5%.
The preparation of said composition comprises the steps: to adopt known chemical method extraction separation to obtain the Os Bovis grunniens crystal Os Bovis grunniens; And extraction yak liver extract; Os Bovis grunniens crystal and yak liver extract, Colla Corii Asini, Flos Carthami extract powder can be made compositions by above-mentioned weight percentage mixing.
Embodiment two:
A kind of anti-osteoporotic composition is made health product by following raw materials in percentage by weight: Os Bovis grunniens crystal 60%, yak liver extract 20%, Colla Corii Asini 10%, Flos Carthami extract powder 10%.
Its preparation method and example are together.
Embodiment three:
A kind of anti-osteoporotic composition is made health product by following raw materials in percentage by weight: Os Bovis grunniens crystal 30%, yak liver extract 45%, Colla Corii Asini 15%, Flos Carthami extract powder 10%.
Its preparation method and example are together.
Embodiment four:
A kind of anti-osteoporotic composition is made health product by following raw materials in percentage by weight: Os Bovis grunniens crystal 25%, yak liver extract 55%, Colla Corii Asini 10%, Flos Carthami extract powder 10%.
Its preparation method and example are together.
Embodiment five:
A kind of anti-osteoporotic composition is made health product by following raw materials in percentage by weight: Os Bovis grunniens crystal 15%, yak liver extract 30%, Colla Corii Asini 25%, Flos Carthami extract powder 30%.
Its preparation method and example are together.
Embodiment six:
A kind of anti-osteoporotic composition is made health product by following raw materials in percentage by weight: Os Bovis grunniens crystal 40%, yak liver extract 10%, Colla Corii Asini 45%, Flos Carthami extract powder 5%.
Its preparation method and example are together.

Claims (3)

1, a kind of anti-osteoporotic composition, said composition comprises following raw materials in percentage by weight:
Os Bovis grunniens crystal 10-80% yak liver extract 5-60%
Colla Corii Asini 5-50% Flos Carthami extract powder 5-50%.
2, anti-osteoporotic composition as claimed in claim 1 is characterized in that said composition comprises the raw material of following weight percentage:
Os Bovis grunniens crystal 25-60% yak liver extract 15-45%
Colla Corii Asini 10-35% Flos Carthami extract powder 10-35%.
3, the preparation method of anti-osteoporotic composition as claimed in claim 1 is characterized in that comprising the steps: Os Bovis grunniens is obtained the Os Bovis grunniens crystal with the chemical method extraction separation; And extraction yak liver extract; Os Bovis grunniens crystal and yak liver extract, Colla Corii Asini, Flos Carthami extract powder can be made compositions by above-mentioned weight percentage mixing.
CNB021455791A 2002-12-17 2002-12-17 Composition for anti osteo porosis Expired - Fee Related CN100387244C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021455791A CN100387244C (en) 2002-12-17 2002-12-17 Composition for anti osteo porosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021455791A CN100387244C (en) 2002-12-17 2002-12-17 Composition for anti osteo porosis

Publications (2)

Publication Number Publication Date
CN1507893A true CN1507893A (en) 2004-06-30
CN100387244C CN100387244C (en) 2008-05-14

Family

ID=34232506

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021455791A Expired - Fee Related CN100387244C (en) 2002-12-17 2002-12-17 Composition for anti osteo porosis

Country Status (1)

Country Link
CN (1) CN100387244C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579562A (en) * 2012-02-27 2012-07-18 苏州爱斯欧蒂生物科技有限公司 Health care product for preventing osteoporosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1161207A (en) * 1996-04-02 1997-10-08 释宽松 Bone-invigorating pill

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579562A (en) * 2012-02-27 2012-07-18 苏州爱斯欧蒂生物科技有限公司 Health care product for preventing osteoporosis

Also Published As

Publication number Publication date
CN100387244C (en) 2008-05-14

Similar Documents

Publication Publication Date Title
US20060210650A1 (en) Supplemental dietary composition for promoting weight loss
CN101028060A (en) Quelite with health-care function
CN108095072A (en) Small peptide spy's dietary seafood formula is eaten for long-term bed and muscle attenuation syndrome crowd
CN1686182A (en) Pharmaceutical preparation for supplementing calcium, magnesium and vitamin D
CN1259937C (en) Health nutrient capsule and its preparation and use
CN1739389A (en) Intelligent growth promoting granule and its prepn process
CN1507893A (en) Composition for anti osteo porosis
CN1943695A (en) A tortoise preparation and its production technology
CN102451260A (en) Traditional Chinese medicine composition with fatigue relieving function and preparation method thereof
CN107969596A (en) A kind of holothurian freeze-dried powder solid beverage
CN1153665A (en) Spirulina mixture health product and its prepn process
CN1213747C (en) Specific therapeutic composition for treating AIDS
CN106729518A (en) A kind of tea beverage of hypotensive and preparation method and application
CN103211868A (en) Composition for preventing osteoporosis
CN110353198A (en) A kind of double ginseng solid pharmaceutical preparations of red yeast rice that suitable spacefarer improves cardiovascular and cerebrovascular
CN1416872A (en) Health wine for expelling wind, clearing away cold and removing dampness
CN107970437A (en) Cordyceps sinensis gram oncogene peptide
CN1562129A (en) Seabuckthora fruit and lucid ganoderma nutrition mixture with auxiliary anti-cancer function
CN1304036C (en) Blood pressure reducing and blood fat removing healthy compositions
CN1061239C (en) Agent with special effect for curing Acquired Immunity Deficiency Syndrome
CN1156296C (en) Oral liquid 'Gubao' and its preparing process
CN1151829C (en) medicine for treating scrofula and lymphoma
CN1226040C (en) Anti-anoxia health food composition
CN1198630C (en) Medicine containing dragonfly and male silkworm moth
CN1054733C (en) Tea polyphenol health products

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080514

Termination date: 20101217